Lipocine Inc.
LPCN
$7.67
$0.385.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.63M | -5.48M | -4.51M | -5.37M | 8.40K |
| Total Depreciation and Amortization | 60.80K | 61.40K | 55.80K | 48.20K | 41.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.50K | 39.80K | -177.80K | -218.20K | -306.50K |
| Change in Net Operating Assets | -243.50K | 234.70K | -357.20K | -57.90K | -964.30K |
| Cash from Operations | -9.76M | -5.14M | -4.99M | -5.60M | -1.22M |
| Capital Expenditure | -- | -10.00K | -90.10K | -90.10K | -90.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.89M | 5.09M | 5.49M | 5.74M | 2.54M |
| Cash from Investing | 5.89M | 5.08M | 5.40M | 5.65M | 2.45M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.87M | 216.90K | 75.60K | 209.30K | 209.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 8.10K | 0.00 |
| Cash from Financing | 2.87M | 216.90K | 75.60K | 217.40K | 209.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.00M | 158.20K | 490.70K | 273.30K | 1.43M |